Resilience Therapeutics raises $975,000 to target PTSD.
Resilience Therapeutics, a US-based life sciences firm led by former Navy Seal Jeff Sabados, has raised $975,000 out of an overall planned $3m raise in a bid to developing a cure for post-traumatic stress disorder (PTSD).
Investors in the round include research lab PsychoGenics and Jason Fuller, principal at New Enterprise Associates. Resilience hopes to close the remaining $2m by the end of March.
Resilience is licensing intellectual property from Emory, Vermont, and Tulane universities, as well as the Scripps…
